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Background and aims: Constipation is one of the most common issues in pediatrics. The aim of this study was to compare the effect of 
polyethylene glycol and the simultaneous administration of polyethylene glycol along with probiotics in the treatment of chronic functional 
constipation.
Materials and Methods: In this randomized double-blind clinical trial, 150 children with chronic functional constipation referred to Imam 
Ali Clinic affiliated with Shahrekord University of Medical Sciences from 2017 to 2018 were included. The first group (A) consumed 1 g/
kg of body weight per day of water-soluble polyethylene glycol powder and the second group (B) consumed a probiotic powder and 1 g/kg 
of body weight of the water-soluble polyethylene glycol powder daily. In weeks 0, 1, and 2, questionnaires were filled out by the parents 
of the children and the data were analyzed.
Results: The results showed that there was no significant difference in any of the variables between groups A and B (P = 0.07) including 
the frequency of fecal excretion in week 1 (77% and 71%) and week 2 (4% and 5.4%) and stool consistency in week 1 (4% and 6.7%) 
and week 2 (86.7% and 92%). Moreover, there was no significant difference between groups A and B in any of the variables frequency of 
painful excretion in week 1 (74% and 73%, respectively) and week 2 (5.3% and 4%, respectively), frequency of abdominal pain in week 
1 (61.3% and 49.3%, respectively) and week 2 (4% and 5.3%, respectively), and the frequency of fecal incontinence in week 1 (22.77% 
and 18.7%, respectively) and week 2 (6.7% and 1.3%) (P > 0.05, respectively).
Conclusion: Our results indicated that the administration of probiotic supplement (Lactobacillus Rhamnosus, Lactobacillus acidophilus, 
Lactobacillous Bulgaricus) has no effect on the improvement of symptoms in children with chronic constipation.
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Introduction
Constipation is a difficulty of stool excretion, painful 
excretion, or stool retention less than two times in a week 
(1).  Acute constipation refers to painful excretion of stool. 
The acute constipation may cause closure of the intestine 
that may require surgery.
It has been reported that nearly 5%-20% of individuals 
suffer from constipation (1). However, the prevalence of 
functional constipation is different in different societies. 
In Iran, the prevalence of constipation was reported to 
range from 1.4 to 37% and the prevalence of functional 
constipation ranged from 2.4 to 11.2% (2). It seems 
that  various factors are involved in the pathogenesis of 
the disease, including sex, age, socio-economic status, and 
education level. The prevalence of constipation among 
children was reported to range from 3-8% (1). However, 
this is different in different age groups. A study has reported 
a prevalence of 16% for children aged 22 months old, and 
another study reported that 34% of children aged 4-11 
years old suffered from constipation (3). The prevalence of 
constipation depends on family history, nutritional habits 
of individuals, age, sex, and stress (4).
There are various factors for constipation that are 
categorized into two types, organic and functional. Organic 
factors include psychological, musculoskeletal, bowel 
neuromuscular, spinal, pharmaceutical, metabolic, bowel, 
and connective tissue disorders. As an organic factor, family 
history accounts for 5%-28% of children with constipation 
and the prevalence of constipation is more common in 
monozygotic twins than in dizygotic twins. This disease 
occurs in all social classes and other factors including 
genetics, socio-economic status, low fiber consumption, 
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and inadequate liquid consumption are among the various 
causes of constipation (5-7). Functional factors include 
cancers, diabetes, thyroid dysfunction, physical inactivity, 
pharmacotherapy, and pregnancy (1).
The effect of probiotics was also investigated in 
previous studies. Probiotics are living microorganisms that 
produce beneficial effects on the gastrointestinal system 
by balancing bowel microbial flora if administered in 
adequate amounts (8).
The effect of probiotics on the treatment of functional 
constipation has been confirmed in recent studies. These 
studies showed that this effect was due to the reduction of 
pH of the colon (9).
Polyethylene glycol is an osmotic laxative that is absorbed 
in small amounts from the gastrointestinal tract (10). It is 
the most effective and safest laxative that has long been 
administered to children (11). Polyethylene glycol is a 
water-soluble polymer with a high molecular weight that 
can produce hydrogen chains with 100 molecules of water 
in each polyethylene glycol molecule.
Nurko et al investigated the safety of polyethylene glycol 
in the treatment of chronic constipation in children. 
They selected children over 2 years and treated them 
with polyethylene glycol for 8 months. All patients were 
evaluated for liver and renal functions, electrolytes status, 
and acid and alkaline states. Its side effects were detected 
to be 0% with a confidence coefficient of 95% (12).
However, constipation is a common problem in 
pediatrics which can cause negative physical and mental 
effects on children and their families. In addition, it can 
be an underlying cause of the other conditions such as 
infections of the urinary tract, anal and rectal prolapse, 
child weight reduction, and social and mental problems. 
The most commonly used standardized treatments 
include laxatives, but despite their widespread use, the 
success rate of this therapeutic method is low. Therefore, 
complementary or alternative therapies should be used 
to increase this success rate. In recent years, the use of 
probiotic agents that contain living microorganisms has 
become widespread, as complementary therapies, for 
various diseases including digestive disorders. Probiotics 
are effective in balancing the microbial microflora of the 
gastrointestinal system. Therefore, this study aimed to 
comparatively investigate the effect of polyethylene glycol 
and the simultaneous administration of polyethylene 
glycol along with probiotics on the treatment of chronic 
functional constipation in children. The secondary 
objectives of the study were to comparatively investigate 
the frequency of stool excretion and painful stool excretion 
during one week, stool consistency, the frequency of 
unwanted stool excretion during one week and abdominal 
pain during one week.
Materials and Methods
This randomized clinical trial study was conducted 
on children with chronic functional constipation who 
referred to Imam Ali Clinic affiliated with Shahrekord 
University of Medical Sciences during 2017-2018. First, 
the necessary explanations were presented to the parents 
regarding the procedure of the study and the informed 
consent form was signed by the children’s legal parents. 
Both the patient and the nurse were blind to the type 
of prescribed drugs. However, we assured parents of the 
children that these drugs were not harmful to them. 
The individual characteristics of the children were kept 
confidential. The sample size was determined using the 
according to the formula below (13):
The project was approved by the Deputy of Research 
and Technology of Shahrekord University of Medical 
Sciences. Then, 150 patients with chronic functional 
constipation were selected based on the inclusion and 
exclusion criteria and randomly divided into 2 groups of 
75 patients. Randomization was conducted by numbering 
and coding each patient and 75 patients were randomly 
selected for the intervention group and 75 patients were 
selected for the control group (Figure 1). The inclusion 
criteria were having chronic functional constipation, 
being 2-15 years of age, and not having large and small 
bowel disease, and having allergy to polyethylene glycol, 
bowel obstruction, and kidney and heart diseases. The 
exclusion criteria included diarrhea and unwanted allergic 
reactions after the administration of drug. Each group 
was divided into two subgroups: 2-7 years and 7-15 years 
old. Additionally, both groups were matched by age, sex, 
and duration of disease. Both the patient and the nurse 
were blind to the type of prescribed drugs. However, 
we assured parents of the children that these drugs were 
not harmful to them. Group A received 1 g/kg of the 
body’s weight of the polyethylene glycol powder with 
water, and group B received a sachet of probiotic powder 
(Lactobacillus Rhamnosus, Lactobacillus acidophilus, 
Lactobacillous Bulgaricus) and 1 g/kg of the body weight 
of water-soluble polyethylene glycol powder. The same 
dietary recommendations were considered for both 
groups. In addition, the necessary training on using the 
toilet was provided. Moreover, children were advised to 
do physical activities regularly and go to the toilet after 
having a meal. The ethical considerations of the study 
were taken into account. Children participated in the 
study after their mothers provided informed written 
consent for their participation. The patient information 
was kept confidential. The necessary information was 
provided for the patients. The patients who suffered 
from complications were excluded from the study. Since 
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there was an intervention in the study, we attempted to 
avoid any complications in the children. In case of any 
complication, they were excluded from the study. No 
charge was imposed on the patients. Questionnaires were 
completed in weeks 0, 1, and 2 by parents of patients and 
the data were analyzed by statistical statistics. Data were 
collected using a checklist. Forms were completed without 
names. Then, they were encoded and physicians did not 
see this process. The data was entered into the SPSS. 
Data were analyzed using descriptive statistics (frequency, 
percentage, mean, and standard deviation) and analytical 
statistics (Fisher’s exact test). A P value of less than 0.05 
was considered statistically significant. 
Results
Each group was divided into two subgroups of 2 to 7 years 
and 7 to 15 years. Both groups were matched for age, sex, 
and duration of the disease and there was no significant 
difference in demographic characteristics between the two 
groups (P > 0.05).  
Changes in the frequency of excretion in the first week 
after the initiation of treatment (week 1) in the first visit 
did not show a significant difference (P = 0.06) (Table 1). 
Fifty-eight patients (77%) in group A and 54 patients 
(72%) in group B showed changes, indicating that the 
difference between the two groups based on the Fisher’s 
exact test was not significant ( )
2
2(x 4.543=  and P = 0.07). 
This comparison was done in the second week after 
treatment using Fisher’s exact test, and the differences in 
the changes in the frequency of excretion between the two 
groups within one week were not statistically significant 
( )
2
2(x 0.150=  and P = 0.09) (Table 1).
The changes in stool consistency in the first week after 
treatment are presented in Table 1. Additionally, the 
comparison of groups A and B for the changes in the stool 
consistency during the first week after treatment by Fisher’s 
exact test showed that there was no significant difference 
( )
2
1 (x 0.528=  and P = 0.06).
Moreover, this comparison was done in the second week 
after treatment using Fisher’s exact test, and no significant 
difference in the stool consistency between the two groups 
was observed ( )
2
2 (x 1.262=  and P = 0.05).
The data drawn from questionnaires on the frequency of 
painful excretion per week showed that it increased in the 
first week of treatment in  56 patients in group A and 55 
patients in group B; however, 19 patients in both groups 
had an unchanged state. This difference between the two 
groups based on  Fisher’s exact test was not significant 
( )
2
2(x 1.009=  and P = 0.09) (Table 2).
According to the data obtained in the second week of 
treatment, the frequency of painful excretion in most 
patients remained unchanged and comparisons did not 
show any significant difference ( )
2
2(x 1.171=  and P = 0.07) 
(Table 2).
The incidence of fecal incontinence in the first visit 
did not change in 56 cases and it decreased in 17 cases in 
group A, in 60 patients in group B did not change, and in 
14 cases, it reduced. This variable did not change in most 







Figure 1. Flow Diagram of the Study Procedure.
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and 1 case in group B  had fecal incontinence (Table 2).
The frequency of fecal incontinence also varied between 
the two groups in the first week ( )
2
2(x 0.762=  and P=0.08) 
and the second week. There was no significant difference 
in this variable between the two groups ( )
2
1(x 2.778=  and 
P=0.06).
Discussion
Our study showed that probiotic agents do not have any 
significant effect on the improvement of the frequency 
of excretion, bowel incontinence, and abdominal pain, 
which is inconsistent with the studies conducted on 
adults; this underlines the hypothesis that constipation in 
children and adults is significantly different. Our results 
also showed that there was not any significant difference 
between groups A and B in the variables frequency of 
stool excretion, stool consistency, painful excretion, 
abdominal pain, and fecal incontinence. There was no 
significant relationship between the studied variables and 
the administration of probiotic agents.
Probiotics contain living microorganisms that appear 
to be a potential contributor to digestive problems by 
competing with pathogenic bacteria. The bacteria in these 
materials, by producing short-chain fatty acids, lactic acid, 
and acetic acid, reduce the pH of the colon and change 
its flora, which in turn affects the movements of the small 
bowel (14,15). Our study showed that the administration 
of probiotic agents had no statistically significant effect on 
the signs of chronic constipation in children. Moreover, in 
terms of the other clinical outcomes, the differences were 
generally in favor of probiotics (16). Some of the results of 
our study were consistent with those of systematic studies 
on the effects of laxative and diet on the management 
of chronic constipation in childhood and studies that 
Table 2. The frequency of painful excretion, abdominal pain and stool incontinence (sudden excretion of gas or liquid)
Variables Visit Group
Decrease Constant Increase Sum
No. (%) No. (%) No. (%) No. (%)
Painful excretion
Week 1
Group B 1 (1.3) 19 (25.3) 56 (73.3) 75 (100)
Group A 0 (0) 19 (25.3) 56 (74.7) 75 (100)
Total 1 (7) 38 (25.3) 111 (74) 150 (100)
Week 2
Group B 1 (1.3) 71 (94.7) 3 (4) 75 (100)
Group A 0 (0) 71 (94.7) 4 (5.3) 75 (100)
Total 1 (7) 142 (94.7) 7 (4.7) 150 (100)
Abdominal pain
Week 1
Group B 4 (5.3) 34 (45.3) 37 (49.3) 75 (100)
Group A 2 (2.7) 27 (36.0) 46 (61.3) 75 (100)
Total 6 (4.0) 61 (40.7) 83 (55.3) 150 (100)
Week 2
Group B 1 (1.3) 70 (93.3) 4 (5.3) 75 (100)
Group A 0 (0) 72 (96.0) 3 (4.0) 75 (100)
Total 1 (7) 142 (94.7) 7 (4.7) 150 (100)
Fecal incontinence 
(sudden excretion of 
gas or liquid)
Week 1
Group B 1 (1.3) 60 (80.0) 14 (18.7) 75 (100)
Group A 2 (2.7) 56 (74.7) 17 (22.7) 75 (100)
Total 3 (2.0) 116 (77.3) 31 (20.7) 150 (100)
Week 2
Group B - 74 (98.7) 1 (1.3) 75 (100)
Group A - 70 (93.3) 5 (6.7) 75 (100)
Total - 144 (96.0) 6 (4.0) 150 (100)
Table 1. Changes in the frequency of the stool excretion, and the stool consistency (soft or rigid)
Variables Visit Group
Decrease Constant Increase Sum
No. (%) No. (%) No. (%) No. (%)
Stool excretion
Week 1
Group B 0 (0) 21 (28) 54 (72) 75 (100)
Group A 3 (4) 14 (18.7) 58 (77.3) 75 (100)
Total 3 (2) 35 (23.3) 112 (74.7) 150 (100)
Week 2
Group B 4 (5.3) 67 (89.3) 4 (5.3) 75 (100)
Group A 4 (5.3) 68 (90.7) 3 (4) 75 (100)
Total 8 (5.3) 135 (90) 7 (4.7) 150 (100)
Stool consistency
Week 1
Group B 70 (93.3) 5 (6.7) - 75 (100)
Group A 72 (96) 3 (4) - 75 (100)
Total 142 (94.7) 8 (5.3) - 150 (100)
Week 2
Group B 3 (4) 69 (92) - 75 (100)
Group A 6 (8) 65 (86.7) - 75 (100)
Total 9 (6) 134 (89.3) - 150 (100)
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investigated the effects of probiotics (16-19). Therefore, 
further studies in this regard seem necessary.
Constipation in children differs considerably from that 
in adults in terms of the incidence, cause, symptoms, 
treatment, and prognosis (16, 12).
In most studies, the administration of probiotics has 
improved the frequency of excretion, which can be due 
to the changes in the bowel flora. Studies have also been 
done to evaluate the intestinal microflora (20). In our 
study, we combined probiotic materials with polyethylene 
glycol and did not achieve more promising results. We 
could not find out whether these two combinations 
interacted together and neutralized the effect of flora. Our 
study is in agreement with other studies because each of 
them (polyethylene glycol and probiotic materials) alone 
showed positive effects; however, our results regarding their 
combination in the children are not consistent with other 
studies (12,16,20). It may be due to participants or flora. 
Further studies should be done on the amount of flora 
in the probiotic materials combined with polyethylene 
glycol and polyethylene alone. Although differences in the 
improvement of various symptoms can be due to different 
diets followed by patients, the mixture of probiotics 
can also explain these differences (21). In addition, the 
evaluation of patients’ condition in some studies was 
done at longer intervals after treatment and the treatment 
response was desirable (11,22).
By evaluating the gastrointestinal microflora in patients 
who consumed probiotic agents and conducting longer 
and more accurate studies, a new therapeutic method 
can be designed to control the symptoms of chronic 
constipation in children. The use of therapeutic strategies 
that include probiotic drugs may help to achieve more 
accurate therapeutic guidelines which can be added to 
current treatments recommended for the management of 
chronic constipation in children (22).
Our study showed that the administration of probiotic 
agents combined with polyethylene glycol did not have 
any significant effect on the improvement of the frequency 
of excretion, fecal incontinence and abdominal pain 
compared to polyethylene glycol alone. This difference 
may be due to the fact that our study was performed on 
the children and other studies were conducted on the 
adults (12,16). This point emphasizes that constipation in 
children is considerably different from that in adults.
Conclusion
Our results indicate that the administration of probiotic 
supplement (Lactobacillus Rhamnosus, Lactobacillus 
acidophilus, Lactobacillous Bulgaricus) has no effect on 
the improvement of disease in children with chronic 
constipation. In other words, the comparison of 
simultaneous administration of the polyethylene glycol 
with probiotics and polyethylene glycol alone did not 
show a considerable difference in the treatment of the 
chronic functional constipation. However, our study had a 
limitation. The patient’s diet was not evaluated due to the 
lack of adequate time. Hence, further studies are needed 
to investigate this issue. However, the efficacy of probiotic 
compounds in improving chronic constipation in children 
was not considerable.
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